University Hospital of Wales, Cardiff, CF14 4XW, United Kingdom; Former Senior Resident, Department of Urology, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham (Amrita University), Ponekkara, Cochin, Kerala, 682041, India.
Former Senior Resident, Department of Urology, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham (Amrita University), Ponekkara, Cochin, Kerala, 682041, India.
Indian J Tuberc. 2021 Jan;68(1):65-72. doi: 10.1016/j.ijtb.2020.08.018. Epub 2020 Aug 26.
Non-tuberculous mycobacterial (NTM) infections are rarely reported, and more so with genitourinary infections. This retrospective study was designed to understand the proportion and behaviour of genitourinary non-tuberculous mycobacterial (GU-NTM) infections compared with genitourinary mycobacterial tuberculosis (GU-MTB) treated at a tertiary care hospital in South India.
The hospital records of every bacteriologically proved GU-MTB and GU-NTM infections treated at this centre from 2010 to 2016 were retrospectively reviewed.
There were ten patients of GU-NTM and 15 patients of GU-MTB. There was no significant difference in presentation other than lesser frequency of irritative lower urinary tract symptoms (LUTS) among patients with GU-MTB. Urine smear for AFB was positive in 60% and 47% of GU-NTM and GU-MTB patients. 40% of GU-NTM patients had history of urinary tract instrumentation. Mycobacterium abscessus was grown in four patients and one had Mycobacterium fortuitum/chelonae complex; all the rest were rapid growers. No patient had multi-drug resistant tuberculosis. Imaging studies of GU-NTM patients were indistinguishable from GU-MTB with renal, ureteral and bladder involvements, and stone formation. The drug sensitivities varied among the NTM patients but all showed sensitivity to clarithromycin uniformly. Need for varieties of surgeries in the early and late phases were also comparable.
GU-MTB and GU-NTM infections are indistinguishable from their clinical presentation and imaging studies. All cases of suspected genitourinary mycobacterial infections must be subjected to nucleic acid testing. Treatments based on clinical and radiological features without culture studies may misdiagnose GU-NTM infections as MDR GU-MTB, thereby delaying the appropriate treatment.
非结核分枝杆菌(NTM)感染很少见,尤其是泌尿生殖系统感染。本回顾性研究旨在了解与在印度南部一家三级保健医院治疗的泌尿生殖系统结核分枝杆菌(GU-MTB)相比,泌尿生殖系统非结核分枝杆菌(GU-NTM)感染的比例和特征。
对 2010 年至 2016 年在该中心经细菌学证实的 GU-MTB 和 GU-NTM 感染患者的医院记录进行回顾性分析。
GU-NTM 患者 10 例,GU-MTB 患者 15 例。除 GU-MTB 患者的刺激性下尿路症状(LUTS)频率较低外,两者的表现无明显差异。GU-NTM 和 GU-MTB 患者的尿液 AFB 涂片阳性率分别为 60%和 47%。40%的 GU-NTM 患者有尿路器械检查史。4 例培养出脓肿分枝杆菌,1 例培养出偶然分枝杆菌/龟分枝杆菌复合体;其余均为快速生长分枝杆菌。无患者患有耐多药结核病。GU-NTM 患者的影像学表现与 GU-MTB 相似,均有肾脏、输尿管和膀胱受累及结石形成。GU-NTM 患者的药敏试验结果各不相同,但对克拉霉素均敏感。早期和晚期需要各种手术的情况也相似。
GU-MTB 和 GU-NTM 感染在临床表现和影像学研究方面无法区分。所有疑似泌尿生殖系统分枝杆菌感染的病例均必须进行核酸检测。如果不进行培养研究而根据临床和影像学特征进行治疗,可能会误诊 GU-NTM 感染为耐多药 GU-MTB,从而延误适当的治疗。